Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.

MicroRNAs (miRNAs) regulate post-transcriptional gene expression during development and disease. We have determined the miRNA expression levels of early- and end-stage hypertrophic cardiomyopathy (HCM) in a severe, transgenic mouse model of the disease. Five miRNAs were differentially expressed at a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Richard D Bagnall, Tatiana Tsoutsman, Rhian E Shephard, William Ritchie, Christopher Semsarian
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/54c9e277339248f1b3d06f906e6953ef
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:54c9e277339248f1b3d06f906e6953ef
record_format dspace
spelling oai:doaj.org-article:54c9e277339248f1b3d06f906e6953ef2021-11-18T07:05:32ZGlobal microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.1932-620310.1371/journal.pone.0044744https://doaj.org/article/54c9e277339248f1b3d06f906e6953ef2012-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0044744https://doaj.org/toc/1932-6203MicroRNAs (miRNAs) regulate post-transcriptional gene expression during development and disease. We have determined the miRNA expression levels of early- and end-stage hypertrophic cardiomyopathy (HCM) in a severe, transgenic mouse model of the disease. Five miRNAs were differentially expressed at an early stage of HCM development. Time-course analysis revealed that decreased expression of miR-1 and miR-133a commences at a pre-disease stage, and precedes upregulation of target genes causal of cardiac hypertrophy and extracellular matrix remodelling, suggesting a role for miR-1 and miR-133a in early disease development. At end-stage HCM, 16 miRNA are dysregulated to form an expression profile resembling that of other forms of cardiac hypertrophy, suggesting common responses. Analysis of the mRNA transcriptome revealed that miRNAs potentially target 15.7% upregulated and 4.8% downregulated mRNAs at end-stage HCM, and regulate mRNAs associated with cardiac hypertrophy and electrophysiology, calcium signalling, fibrosis, and the TGF-β signalling pathway. Collectively, these results define the miRNA expression signatures during development and progression of severe HCM and highlight critical miRNA regulated gene networks that are involved in disease pathogenesis.Richard D BagnallTatiana TsoutsmanRhian E ShephardWilliam RitchieChristopher SemsarianPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e44744 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Richard D Bagnall
Tatiana Tsoutsman
Rhian E Shephard
William Ritchie
Christopher Semsarian
Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
description MicroRNAs (miRNAs) regulate post-transcriptional gene expression during development and disease. We have determined the miRNA expression levels of early- and end-stage hypertrophic cardiomyopathy (HCM) in a severe, transgenic mouse model of the disease. Five miRNAs were differentially expressed at an early stage of HCM development. Time-course analysis revealed that decreased expression of miR-1 and miR-133a commences at a pre-disease stage, and precedes upregulation of target genes causal of cardiac hypertrophy and extracellular matrix remodelling, suggesting a role for miR-1 and miR-133a in early disease development. At end-stage HCM, 16 miRNA are dysregulated to form an expression profile resembling that of other forms of cardiac hypertrophy, suggesting common responses. Analysis of the mRNA transcriptome revealed that miRNAs potentially target 15.7% upregulated and 4.8% downregulated mRNAs at end-stage HCM, and regulate mRNAs associated with cardiac hypertrophy and electrophysiology, calcium signalling, fibrosis, and the TGF-β signalling pathway. Collectively, these results define the miRNA expression signatures during development and progression of severe HCM and highlight critical miRNA regulated gene networks that are involved in disease pathogenesis.
format article
author Richard D Bagnall
Tatiana Tsoutsman
Rhian E Shephard
William Ritchie
Christopher Semsarian
author_facet Richard D Bagnall
Tatiana Tsoutsman
Rhian E Shephard
William Ritchie
Christopher Semsarian
author_sort Richard D Bagnall
title Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
title_short Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
title_full Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
title_fullStr Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
title_full_unstemmed Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
title_sort global microrna profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/54c9e277339248f1b3d06f906e6953ef
work_keys_str_mv AT richarddbagnall globalmicrornaprofilingofthemouseventriclesduringdevelopmentofseverehypertrophiccardiomyopathyandheartfailure
AT tatianatsoutsman globalmicrornaprofilingofthemouseventriclesduringdevelopmentofseverehypertrophiccardiomyopathyandheartfailure
AT rhianeshephard globalmicrornaprofilingofthemouseventriclesduringdevelopmentofseverehypertrophiccardiomyopathyandheartfailure
AT williamritchie globalmicrornaprofilingofthemouseventriclesduringdevelopmentofseverehypertrophiccardiomyopathyandheartfailure
AT christophersemsarian globalmicrornaprofilingofthemouseventriclesduringdevelopmentofseverehypertrophiccardiomyopathyandheartfailure
_version_ 1718423915538153472